Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 4, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Cecilia Furlong Maintained (TMDX) at Hold with Increased Target to $25 on, May 4th, 2022
Cecilia Furlong of Morgan Stanley, Maintained "TransMedics Group, Inc." (TMDX) at Hold with Increased Target from $15 to $25 on, May 4th, 2022.
Cecilia has made no other calls on TMDX in the last 4 months.
There are 2 other peers that have a rating on TMDX. Out of the 2 peers that are also analyzing TMDX, 1 agrees with Cecilia's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $15 on, Friday, February 25th, 2022
This is the rating of the analyst that currently disagrees with Cecilia
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $39 on, Thursday, March 17th, 2022
